Global Drug Repositioning Competitive Landscape Professional Research Report 2025
Research Summary
Drug repositioning, also known as drug repurposing, is the process of identifying new therapeutic uses for existing drugs that were originally developed for different purposes. Rather than starting from scratch to discover and develop a new drug, drug repositioning involves investigating the potential benefits of established drugs in treating different diseases or conditions. This approach leverages existing safety and efficacy data, expediting the development timeline and potentially reducing costs. Drug repositioning involves a combination of computational analyses, laboratory experiments, and clinical studies to explore the potential of existing compounds in addressing unmet medical needs or expanding their applications beyond their initial intended uses. This strategy has gained prominence as a promising way to bring new treatments to patients more efficiently and with a higher probability of success.
According to DIResearch's in-depth investigation and research, the global Drug Repositioning market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Drug Repositioning include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, Bausch Health, GSK, Glenmark, ChemRar Group, Fujifilm, Dr. Reddy, R-Pharma etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Drug Repositioning. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drug Repositioning market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drug Repositioning market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drug Repositioning industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Drug Repositioning Include:
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
Glenmark
ChemRar Group
Fujifilm
Dr. Reddy
R-Pharma
Drug Repositioning Product Segment Include:
Generic Drugs
Clinical Trial Failed Drugs
Drug Repositioning Product Application Include:
Cardiovascular Diseases
Mental Illness
Cancer
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Drug Repositioning Industry PESTEL Analysis
Chapter 3: Global Drug Repositioning Industry Porter’s Five Forces Analysis
Chapter 4: Global Drug Repositioning Major Regional Market Size and Forecast Analysis
Chapter 5: Global Drug Repositioning Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Drug Repositioning Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Drug Repositioning Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Drug Repositioning Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Drug Repositioning Product by Type
- 1.2.1 Generic Drugs
- 1.2.2 Clinical Trial Failed Drugs
- 1.3 Drug Repositioning Product by Application
- 1.3.1 Cardiovascular Diseases
- 1.3.2 Mental Illness
- 1.3.3 Cancer
- 1.3.4 Others
- 1.4 Global Drug Repositioning Market Size Analysis (2020-2032)
- 1.5 Drug Repositioning Market Development Status and Trends
- 1.5.1 Drug Repositioning Industry Development Status Analysis
- 1.5.2 Drug Repositioning Industry Development Trends Analysis
- 2 Drug Repositioning Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Drug Repositioning Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Drug Repositioning Market Analysis by Regions
- 4.1 Drug Repositioning Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Drug Repositioning Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Drug Repositioning Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Drug Repositioning Revenue Forecast by Region (2026-2032)
- 5 Global Drug Repositioning Market Size by Type and Application
- 5.1 Global Drug Repositioning Market Size by Type (2020-2032)
- 5.2 Global Drug Repositioning Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Drug Repositioning Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Drug Repositioning Market Size by Type
- 6.4 North America Drug Repositioning Market Size by Application
- 6.5 North America Drug Repositioning Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Drug Repositioning Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Drug Repositioning Market Size by Type
- 7.4 Europe Drug Repositioning Market Size by Application
- 7.5 Europe Drug Repositioning Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Drug Repositioning Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Drug Repositioning Market Size by Type
- 8.4 China Drug Repositioning Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Drug Repositioning Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Drug Repositioning Market Size by Type
- 9.4 APAC (excl. China) Drug Repositioning Market Size by Application
- 9.5 APAC (excl. China) Drug Repositioning Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Drug Repositioning Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Drug Repositioning Market Size by Type
- 10.4 Latin America Drug Repositioning Market Size by Application
- 10.5 Latin America Drug Repositioning Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Drug Repositioning Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Drug Repositioning Market Size by Type
- 11.4 Middle East & Africa Drug Repositioning Market Size by Application
- 11.5 Middle East & Africa Drug Repositioning Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Drug Repositioning Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Drug Repositioning Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Drug Repositioning Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Teva
- 13.1.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Teva Drug Repositioning Product Portfolio
- 13.1.3 Teva Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Novartis
- 13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Novartis Drug Repositioning Product Portfolio
- 13.2.3 Novartis Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Mylan
- 13.3.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Mylan Drug Repositioning Product Portfolio
- 13.3.3 Mylan Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 Johnson & Johnson
- 13.4.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Johnson & Johnson Drug Repositioning Product Portfolio
- 13.4.3 Johnson & Johnson Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Pfizer
- 13.5.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Pfizer Drug Repositioning Product Portfolio
- 13.5.3 Pfizer Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Bausch Health
- 13.6.1 Bausch Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Bausch Health Drug Repositioning Product Portfolio
- 13.6.3 Bausch Health Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 GSK
- 13.7.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 GSK Drug Repositioning Product Portfolio
- 13.7.3 GSK Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Glenmark
- 13.8.1 Glenmark Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Glenmark Drug Repositioning Product Portfolio
- 13.8.3 Glenmark Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 ChemRar Group
- 13.9.1 ChemRar Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 ChemRar Group Drug Repositioning Product Portfolio
- 13.9.3 ChemRar Group Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Fujifilm
- 13.10.1 Fujifilm Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Fujifilm Drug Repositioning Product Portfolio
- 13.10.3 Fujifilm Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Dr. Reddy
- 13.11.1 Dr. Reddy Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Dr. Reddy Drug Repositioning Product Portfolio
- 13.11.3 Dr. Reddy Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 R-Pharma
- 13.12.1 R-Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 R-Pharma Drug Repositioning Product Portfolio
- 13.12.3 R-Pharma Drug Repositioning Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Drug Repositioning Industry Chain Analysis
- 14.2 Drug Repositioning Industry Raw Material and Suppliers Analysis
- 14.2.1 Drug Repositioning Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Drug Repositioning Typical Downstream Customers
- 14.4 Drug Repositioning Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook